Involvement of myelin integrity in Alzheimer's disease pathogenesis
Involvement of myelin integrity in Alzheimer's disease pathogenesis
批准号:
9267404
负责人:
ADAM D BACHSTETTER
金额:
$24.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2019-04-30
关键词:
Alzheimer&aposs DiseaseAmyloid beta-Protein PrecursorAnimal ModelAreaAutomobile DrivingAutopsyBiochemistryBiologyBrainBrodmann&aposs areaCentral Nervous System DiseasesCerebrumChronicClinicalCognitiveCommunicationDataDeteriorationDevelopment PlansDiffusion Magnetic Resonance ImagingDiseaseDisease ProgressionEducational process of instructingEnvironmentEnzyme-Linked Immunosorbent AssayEventExhibitsGenesGeneticGoalsGrowthHealthHumanImmunohistochemistryInduced MutationInflammationInflammatoryInflammatory ResponseInterleukin-1 betaInternationalKentuckyLate Onset Alzheimer DiseaseMAPT geneMeasuresMedialMediatingMental disordersMentorsMethodsMicrogliaMusMutationMyelinMyelin ProteinsNeocortexNeuregulin 1Neurodegenerative DisordersNeurofibrillary TanglesNeurogliaNeuronsOligodendrogliaPathogenesisPathologicPathologyPathway interactionsPhaseResearchResearch PersonnelResearch Project GrantsResourcesRoleSamplingScientistSenile PlaquesStructureSynapsesTNF geneTemporal LobeTestingTissuesTrainingUniversitiesWhite Matter DiseaseWorkWritingamnestic mild cognitive impairmentaxon injurybeta-site APP cleaving enzyme 1brain tissueburden of illnesscareercareer developmentcollaborative environmentcytokinedesigndigitalfeedingfrontal lobegenetic risk factorgray matterhTau Micehuman tissuehyperphosphorylated tauimprovedinhibitor/antagonistinsightlipid transportmeetingsmouse modelmyelinationneuroinflammationneuron lossneuropathologypre-clinicalpublic health relevanceresponseskillswhite matterwhite matter changeyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This K99/R00 application provides career development training and a research plan to further the understanding of glial responses in white matter in the context of Alzheimer's disease (AD). The hypothesis to be tested is that a progressive loss of myelin integrity occurs in AD, activating microglia towards a proinflammatory feed-forward loop, which mediates hyperphosphorylation of the microtubule-associated protein tau and traditional AD pathology: neuritic plaques (NP) and neurofibrillary tangles (NFTs). Conventionally considered a disease of the CNS gray matter, AD also has pronounced and progressive deterioration of cerebral white matter. Recent evidence suggests that changes in myelin integrity could be an early factor driving AD pathology, through stimulation of inflammatory microglia activation and subsequent axonal damage. Extensive work has been done to understand the glial response in AD gray matter yet very little is known about microglia activation in AD white matter, despite the fact that we and others have found a more robust activation of microglia and inflammatory response in AD white matter compared to gray matter. No studies have systematically and quantitatively examined myelin changes and inflammatory profiles as a function of disease progression. Our project will fill this gap by using human autopsy tissue and a mouse model that exhibits loss of myelin integrity to test our hypothesis. Our specific aims are: 1) Quantify the relationship between myelin integrity, microglia activation,
proinflammatory cytokine levels, and traditional measures of AD burden (NPs and NFTs) in the white matter of autopsy samples; 2) Determine if loss of myelin integrity, induced by mutation in PLP, in hTau mice will accelerate hyper-phosphorylated tau pathology, and if this pathology can be rescued by suppressing the chronic neuroinflammation using a glia cytokine inhibitor. This project takes advantage of a strong scientific environment and extensive resources at the University of Kentucky, including the Alzheimer's Disease Center, clinically well-characterized autopsy cases that span the disease pathology continuum, and renowned scientific expertise of an enthusiastic and committed mentoring team. A comprehensive training and career development plan has been developed for the K99 phase that includes further scientific training in oligodendrocyte/myelin biology and human neuropathology; formal coursework and participation in local, national and international scientific meetings; evaluative meetings with th mentoring team; and activities designed to improve communication, writing, teaching, and management skills. Overall, there is an outstanding intellectual environment and access to relevant expertise in the applicant's project area, multiple opportunities for career growth, and substantial institutional commitment. This rich and supportive environment will enable a highly promising young scientist to further develop his research expertise, pursue his structured training and career development plan, and launch his career as an independent academic investigator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug repurposing for Alzheimer’s disease-related inflammation caused by a TBI
-
批准号:10590132
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2023
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
-
批准号:10518172
-
项目类别:
-
资助金额:$44.24万
-
财政年份:2022
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
-
批准号:10656547
-
项目类别:
-
资助金额:$42.91万
-
财政年份:2022
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Translational Approaches to Mitigate Enhanced Alzheimer’s Disease Risk Following a Mild TBI
-
批准号:10090757
-
项目类别:
-
资助金额:$114.75万
-
财政年份:2021
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Administrative Supplement to Sleep Fragmentation and Alzheimer's Disease
-
批准号:10555721
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10029813
-
项目类别:
-
资助金额:$73.69万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10398182
-
项目类别:
-
资助金额:$74.16万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10219957
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Sleep Fragmentation and Alzheimer’s Disease
-
批准号:10611958
-
项目类别:
-
资助金额:$72.93万
-
财政年份:2020
-
负责人:ADAM D BACHSTETTER
-
依托单位:
SLC9A1 and Neurodegenerative Disease
-
批准号:9898214
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2019
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury
-
批准号:10307112
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2018
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury
-
批准号:10540718
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2018
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Involvement of myelin integrity in Alzheimer's disease pathogenesis
-
批准号:8634180
-
项目类别:
-
资助金额:$8.94万
-
财政年份:2013
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Involvement of myelin integrity in Alzheimer's disease pathogenesis
-
批准号:8776907
-
项目类别:
-
资助金额:$8.57万
-
财政年份:2013
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?
-
批准号:8080960
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2010
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?
-
批准号:7911520
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:ADAM D BACHSTETTER
-
依托单位:
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?
-
批准号:8231475
-
项目类别:
-
资助金额:$2.71万
-
财政年份:2010
-
负责人:ADAM D BACHSTETTER
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: